BR112015004432A2 - derivados de n-acilidrazona para inibidor seletivo de célula t e droga para neoplasia antilinfoide. - Google Patents
derivados de n-acilidrazona para inibidor seletivo de célula t e droga para neoplasia antilinfoide.Info
- Publication number
- BR112015004432A2 BR112015004432A2 BR112015004432A BR112015004432A BR112015004432A2 BR 112015004432 A2 BR112015004432 A2 BR 112015004432A2 BR 112015004432 A BR112015004432 A BR 112015004432A BR 112015004432 A BR112015004432 A BR 112015004432A BR 112015004432 A2 BR112015004432 A2 BR 112015004432A2
- Authority
- BR
- Brazil
- Prior art keywords
- antilymphoid
- acylidrazone
- neoplasia
- selective
- drug
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/14—Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Transplantation (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20120095729 | 2012-08-30 | ||
| KR20120108972 | 2012-09-28 | ||
| PCT/KR2013/007751 WO2014035149A1 (en) | 2012-08-30 | 2013-08-29 | N-acylhydrazone derivatives for selective t cell inhibitor and anti-lymphoid malignancy drug |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112015004432A2 true BR112015004432A2 (pt) | 2017-07-04 |
Family
ID=50183887
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015004432A BR112015004432A2 (pt) | 2012-08-30 | 2013-08-29 | derivados de n-acilidrazona para inibidor seletivo de célula t e droga para neoplasia antilinfoide. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9447083B2 (pt) |
| EP (1) | EP2890677B1 (pt) |
| JP (1) | JP6139682B2 (pt) |
| KR (1) | KR101561987B1 (pt) |
| CN (1) | CN104755460B (pt) |
| AU (1) | AU2013309723B2 (pt) |
| BR (1) | BR112015004432A2 (pt) |
| CA (1) | CA2881797C (pt) |
| ES (1) | ES2651312T3 (pt) |
| IN (1) | IN2015MN00411A (pt) |
| MX (1) | MX368381B (pt) |
| NZ (1) | NZ704807A (pt) |
| PH (1) | PH12015500282B1 (pt) |
| RU (1) | RU2622651C2 (pt) |
| WO (1) | WO2014035149A1 (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106986789B (zh) * | 2016-01-20 | 2019-07-16 | 中国人民解放军军事医学科学院生物医学分析中心 | 对苯二酚类化合物及其制备方法与在抗肿瘤或免疫调节中的应用 |
| TW202028456A (zh) * | 2018-09-28 | 2020-08-01 | 日商日產化學股份有限公司 | 旁泌素因子產生促進用培養基添加劑 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL109309A (en) * | 1993-04-16 | 2000-06-29 | Lilly Co Eli | 1-H-indole-3-acetic acid hydrazide SPLA2 inhibitors and pharmaceutical compositions containing them |
| DE102004037515A1 (de) | 2003-08-22 | 2005-03-17 | Merck Patent Gmbh | Verfahren zur Herstellung von Aldehyden |
| WO2006121684A2 (en) * | 2005-05-06 | 2006-11-16 | Boehringer Ingelheim International, Gmbh | Acyl hydrazones for treating cardiovascular diseases |
| US8283351B2 (en) | 2007-04-02 | 2012-10-09 | Institute For Oneworld Health | Cyclic and acyclic hydrazine derivatives compositions including them and uses thereof |
| AU2008345225A1 (en) | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| WO2009155362A1 (en) * | 2008-06-19 | 2009-12-23 | Ligand Pharmaceuticals Inc. | Small molecule hematopoietic growth factor mimetic compounds and their uses |
| WO2013032907A1 (en) | 2011-08-26 | 2013-03-07 | The Broad Institute, Inc. | Compounds and methods for the treatment of cancer stem cells |
-
2013
- 2013-08-29 CA CA2881797A patent/CA2881797C/en not_active Expired - Fee Related
- 2013-08-29 BR BR112015004432A patent/BR112015004432A2/pt not_active Application Discontinuation
- 2013-08-29 NZ NZ704807A patent/NZ704807A/en not_active IP Right Cessation
- 2013-08-29 AU AU2013309723A patent/AU2013309723B2/en not_active Ceased
- 2013-08-29 MX MX2015002601A patent/MX368381B/es active IP Right Grant
- 2013-08-29 RU RU2015105511A patent/RU2622651C2/ru active
- 2013-08-29 CN CN201380056385.7A patent/CN104755460B/zh not_active Expired - Fee Related
- 2013-08-29 ES ES13833207.7T patent/ES2651312T3/es active Active
- 2013-08-29 US US14/424,749 patent/US9447083B2/en active Active
- 2013-08-29 EP EP13833207.7A patent/EP2890677B1/en not_active Not-in-force
- 2013-08-29 WO PCT/KR2013/007751 patent/WO2014035149A1/en active Application Filing
- 2013-08-29 JP JP2015529676A patent/JP6139682B2/ja not_active Expired - Fee Related
- 2013-08-29 IN IN411MUN2015 patent/IN2015MN00411A/en unknown
- 2013-08-30 KR KR1020130103747A patent/KR101561987B1/ko active IP Right Grant
-
2015
- 2015-02-09 PH PH12015500282A patent/PH12015500282B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP6139682B2 (ja) | 2017-05-31 |
| US20150252030A1 (en) | 2015-09-10 |
| RU2622651C2 (ru) | 2017-06-19 |
| IN2015MN00411A (pt) | 2015-09-04 |
| KR101561987B1 (ko) | 2015-10-20 |
| AU2013309723A1 (en) | 2015-02-26 |
| KR20140029318A (ko) | 2014-03-10 |
| EP2890677B1 (en) | 2017-11-15 |
| MX368381B (es) | 2019-09-30 |
| CN104755460A (zh) | 2015-07-01 |
| WO2014035149A1 (en) | 2014-03-06 |
| PH12015500282A1 (en) | 2015-04-27 |
| NZ704807A (en) | 2016-06-24 |
| US9447083B2 (en) | 2016-09-20 |
| AU2013309723B2 (en) | 2016-07-14 |
| PH12015500282B1 (en) | 2015-04-27 |
| EP2890677A1 (en) | 2015-07-08 |
| ES2651312T3 (es) | 2018-01-25 |
| JP2015526508A (ja) | 2015-09-10 |
| MX2015002601A (es) | 2015-09-29 |
| RU2015105511A (ru) | 2016-10-20 |
| CA2881797A1 (en) | 2014-03-06 |
| CA2881797C (en) | 2017-08-01 |
| EP2890677A4 (en) | 2016-03-09 |
| CN104755460B (zh) | 2017-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015002868A2 (pt) | dispositivos, sistemas e métodos para se engajar tecido | |
| DK2854883T3 (da) | Biomatrix-hydrogeler og fremgangsmåder til anvendelse deraf | |
| DK2906684T3 (da) | T-celle-modificerende forbindelser og anvendelser deraf | |
| BR112015002738A2 (pt) | composto , e , composição farmacêutica | |
| BR112015000891A2 (pt) | embalagem para seringa | |
| BR112014033055A2 (pt) | inibidores seletivos de delta pi3k | |
| BR112013019913A2 (pt) | derivados de benzodiazepina citotóxicos. | |
| DK2920149T3 (da) | 3-aminocycloalkyl-forbindelser som ror-gamma-t-inhibitorer og anvendelser deraf | |
| DK2875005T3 (da) | N-(3-heteroarylaryl)-4-arylarylcarboxamider og analoger som hedgehog pathway inhibitorer, og anvendelse deraf | |
| BR302013002035S1 (pt) | Desenho ornamental para um absorvente higiênico. | |
| BR112015025408A2 (pt) | combinações de droga para tratar câncer | |
| BR112014032488A2 (pt) | embalagem, e blanqueta | |
| DK2917181T3 (da) | Heteroarylderivater og anvendelser deraf | |
| BR112015002824A2 (pt) | composto, uso de um composto, composição farmacêutica, e, produto farmacêutico de combinação. | |
| BR112014024377A2 (pt) | dispositivo amostragem de fluidos e método para amostragem. | |
| ZA201507576B (en) | Pharmaceutical combination drug | |
| CL2014003283A1 (es) | Formulación farmacéutica. | |
| DK2912032T3 (da) | 4-carboxamido-isoindolinonderivater som selektive parp-1-hæmmere | |
| DK3357522T3 (da) | Coatet medicinsk genstand til lægemiddelsfrigivelse | |
| BR112015000557A2 (pt) | rebobinadeira. | |
| BR112014032501A2 (pt) | composto, e, composição farmacêutica. | |
| DK2914229T3 (da) | Lettilgængelige bandager, indpakninger og systemer til anvendelse | |
| IT1399867B1 (it) | Inserto illustrativo per medicinali. | |
| BR112015004432A2 (pt) | derivados de n-acilidrazona para inibidor seletivo de célula t e droga para neoplasia antilinfoide. | |
| BR112014022928A2 (pt) | Unidade de ignição para turborreator, e, sistema de ignição para turborreator |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |